| 1 |
35619841 | Prolonged Response of Metastatic Programmed Death-Ligand 1 (PD-L1) Negative Basaloid Squamous Cell Carcinoma of the Lung to Maintenance Immunotherapy. | 2022 Apr |
1 |
| 2 |
33475294 | Immunotherapy in Triple-Negative Breast Cancer. | 2021 Jan-Feb 01 |
1 |
| 3 |
34359638 | Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer. | 2021 Jul 25 |
1 |
| 4 |
32129476 | The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice. | 2020 Apr |
1 |
| 5 |
32408327 | [A Case of Squamous Cell Lung Cancer in an Elderly Patient with Low PD-L1 Expression Effectively Treated with Nab-Paclitaxel(Nab-PTX)plus Carboplatin (CBDCA)plus Pembrolizumab for a Recurrence after Operation]. | 2020 May |
2 |
| 6 |
32426048 | Cost-effectiveness of adding atezolizumab to first-line chemotherapy in patients with advanced triple-negative breast cancer. | 2020 |
3 |
| 7 |
32450725 | Atezolizumab in the treatment of metastatic triple-negative breast cancer. | 2020 Sep |
1 |
| 8 |
32988260 | Remarkable response to combined immunochemotherapy in patients with metastatic triple-negative breast cancer. | 2020 Dec |
1 |
| 9 |
31231572 | How I treat metastatic triple-negative breast cancer. | 2019 |
1 |
| 10 |
31612909 | Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130). | 2019 Dec 27 |
1 |
| 11 |
31839159 | Targeting immune pathways in breast cancer: review of the prognostic utility of TILs in early stage triple negative breast cancer (TNBC). | 2019 Nov |
1 |
| 12 |
31842957 | Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review. | 2019 Dec 16 |
1 |
| 13 |
32042863 | Predictive biomarkers for immune checkpoint blockade and opportunities for combination therapies. | 2019 Sep |
1 |
| 14 |
30345906 | Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. | 2018 Nov 29 |
1 |
| 15 |
27930644 | Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy. | 2016 Nov |
1 |